Epidemiology and genetics of frontotemporal dementia: A door-to-door survey in Southern Italy

Neurobiology of Aging

Volumn 33, Issue 12, 2012, Pages 2948.e1-2948.e10

  Bernardi, Livia ^a   Frangipane, Francesca ^a   Smirne, Nicoletta ^a   Colao, Rosanna ^a   Puccio, Gianfranco ^a   Curcio, Sabrina A M ^a   Mirabelli, Maria ^a   Maletta, Raffaele ^a   Anfossi, Maria ^a   Gallo, Maura ^a   Geracitano, Silvana ^a   Conidi, Maria Elena ^a   Di Lorenzo, Raffale ^a   Clodomiro, Alessandra ^a   Cupidi, Chiara ^a   Marzano, Sandra ^b   Comito, Francesco ^b   Valenti, Vincenzo ^b   Zirilli, Maria Angela ^b   Ghani, Mahdi ^c   Xi, Zhengrui ^c   Sato, Christine ^c   Moreno, Danielle ^c   Borelli, Annelisa ^a   Leone, Rosa Anna ^a   St George Hyslop, Peter ^c,d,e   Rogaeva, Ekaterina ^c,d   Bruni, Amalia C ^a   more..

^a Regional Neurogenetic Centre   (Italy)

^b Unit of Laboratory ASPRC Reggio Calabria   (Italy)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Door to door study; Frontotemporal dementia; Gene; Mutation; Prevalence studies; Progranulin

Indexed keywords

PROGRANULIN;

AGE DISTRIBUTION; AGED; AGITATION; ALZHEIMER DISEASE; APOE GENE; ARTICLE; C9ORF72 GENE; CARDIOVASCULAR RISK; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE SURVEILLANCE; FEMALE; FRONTOTEMPORAL DEMENTIA; FUS GENE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC VARIABILITY; GRN GENE; HETEROZYGOTE; HUMAN; ITALY; LOSS OF FUNCTION MUTATION; MALE; MAPT GENE; MULTIINFARCT DEMENTIA; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PARANOIA; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TARDBP GENE; TRANSMEMBRANE PROTEIN 106B GENE;

EID: 84866760030     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.06.017     Document Type: Article

References (29)

1. Andreasen N., Blennow K., Sjödin C., Winblad B., Svärdsudd K. Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Piteå Dementia Project. Neuroepidemiology 1999, 18:144-155.
2. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S., Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T., Zehr C., Dickey C.A., Crook R., McGowan E., Mann D., Boeve B., Feldman H., Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442:916-919.
3. Beck J., Rohrer J.D., Campbell T., Isaacs A., Morrison K.E., Goodall E.F., Warrington E.K., Stevens J., Revesz T., Holton J., Al-Sarraj S., King A., Scahill R., Warren J.D., Fox N.C., Rossor M.N., Collinge J., Mead S. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008, 131:706-720.
4. Borroni B., Alberici A., Grassi M., Turla M., Zanetti O., Bianchetti A., Dalla Volta G., Rozzini R., Gilberti N., Bellelli G., Padovani A. Is frontotemporal lobar degeneration a rare disorder?. Evidence from a preliminary study in Brescia county, Italy. J. Alzheimer Dis 2010, 19:111-116.
5. Brun A., Englund B., Gustafson L. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J. Neurol. Neurosurg. Psychiatry 1994, 57:416-418.
6. Bruni A.C., Bernardi L., Colao R., Rubino E., Smirne N., Frangipane F., Terni B., Curcio S.A., Mirabelli M., Clodomiro A., Di Lorenzo R., Maletta R., Anfossi M., Gallo M., Geracitano S., Tomaino C., Muraca M.G., Leotta A., Lio S.G., Pinessi L., Rainero I., Sorbi S., Nee L., Milan G., Pappatà S., Postiglione A., Abbamondi N., Forloni G., St George Hyslop P., Rogaeva E., Bugiani O., Giaccone G., Foncin J.F., Spillantini M.G., Puccio G. Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology 2010, 74:798-806.
7. Bruni A.C., Momeni P., Bernardi L., Tomaino C., Frangipane F., Elder J., Kawarai T., Sato C., Pradella S., Wakutani Y., Anfossi M., Gallo M., Geracitano S., Costanzo A., Smirne N., Curcio S.A., Mirabelli M., Puccio G., Colao R., Maletta R.G., Kertesz A., St.George-Hyslop P., Hardy J., Rogaeva E. Heterogeneity within a large kindred with frontotemporal dementia: A novel progranulin mutation. Neurology 2007, 69:140-147.
8. Cizza G., Bernardi L., Smirne N., Maletta R., Tomaino C., Costanzo A., Gallo M., Lewis J.G., Geracitano S., Grasso M.B., Potenza G., Monteleone C., Brancati G., Ho J.T., Torpy D.J., Bruni A.C. Clinical manifestations of highly prevalent corticosteroid-binding globulin mutations in a village in southern Italy. J. Clin. Endocrinol. Metab 2011, 96:E1684-E1693.
9. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., Van den Broeck M., Cuijt I., Vennekens K., De Deyn P.P., Kumar-Singh S., Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006, 442:920-924.
10. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
11. Diehl-Schmid J., Schūlte-Overberg J., Hartmann J., Förstl H., Kurz A., Häussermann P. Extrapyramidal signs, primitive reflexes and incontinence in fronto-temporal dementia. Eur. J. Neurol 2007, 14:860-864.
12. Fenoglio C., Galimberti D., Cortini F., Kauwe J.S., Cruchaga C., Venturelli E., Villa C., Serpente M., Scalabrini D., Mayo K., Piccio L.M., Clerici F., Albani D., Mariani C., Forloni G., Bresolin N., Goate A.M., Scarpini E. rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease. J. Alzheimers Dis 2009, 18:603-612.
13. Finch N., Baker M., Crook R., Swanson K., Kuntz K., Surtees R., Bisceglio G., Rovelet-Lecrux A., Boeve B., Petersen R.C., Dickson D.W., Younkin S.G., Deramecourt V., Crook J., Graff-Radford N.R., Rademakers R. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 2009, 132:583-591.
14. Finch N., Carrasquillo M.M., Baker M., Rutherford N.J., Coppola G., Dejesus-Hernandez M., Crook R., Hunter T., Ghidoni R., Benussi L., Crook J., Finger E., Hantanpaa K.J., Karydas A.M., Sengdy P., Gonzalez J., Seeley W.W., Johnson N., Beach T.G., Mesulam M., Forloni G., Kertesz A., Knopman D.S., Uitti R., White C.L., Caselli R., Lippa C., Bigio E.H., Wszolek Z.K., Binetti G., Mackenzie I.R., Miller B.L., Boeve B.F., Younkin S.G., Dickson D.W., Petersen R.C., Graff-Radford N.R., Geschwind D.H., Rademakers R. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 2011, 76:467-474.
15. Gass J., Cannon A., Mackenzie I.R., Boeve B., Baker M., Adamson J., Crook R., Melquist S., Kuntz K., Petersen R., Josephs K., Pickering-Brown S.M., Graff-Radford N., Uitti R., Dickson D., Wszolek Z., Gonzalez J., Beach T.G., Bigio E., Johnson N., Weintraub S., Mesulam M., White C.L., Woodruff B., Caselli R., Hsiung G.Y., Feldman H., Knopman D., Hutton M., Rademakers R. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum. Mol. Genet 2006, 15:2988-3001.
16. Ghidoni R., Stoppani E., Rossi G., Piccoli E., Albertini V., Paterlini A., Glionna M., Pegoiani E., Agnati L.F., Fenoglio C., Scarpini E., Galimberti D., Morbin M., Tagliavini F., Binetti G., Benussi L. Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study. Neurodegener. Dis 2012, 9:121-127.
17. Harvey R.J., Skelton-Robinson M., Rossor M.N. The prevalence and causes of dementia in people under the age of 65 years. J. Neurol. Neurosurg. Psychiatry 2003, 74:1206-1209.
18. Ikeda M., Ishikawa T., Tanabe H. Epidemiology of frontotemporal lobar degeneration. Dement. Geriatr. Cogn. Disord 2004, 17:265-268.
19. Le Ber I., Camuzat A., Hannequin D., Pasquier F., Guedj E., Rovelet-Lecrux A., Hahn-Barma V., van der Zee J., Clot F., Bakchine S., Puel M., Ghanim M., Lacomblez L., Mikol J., Deramecourt V., Lejeune P., de la Sayette V., Belliard S., Vercelletto M., Meyrignac C., Van Broeckhoven C., Lambert J.C., Verpillat P., Campion D., Habert M.O., Dubois B., Brice A. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain 2008, 131:732-746. French Research Network on FTD/FTD-MND.
20. Le Ber I., van der Zee J., Hannequin D., Gijselinck I., Campion D., Puel M., Laquerrière A., De Pooter T., Camuzat A., Van den Broeck M., Dubois B., Sellal F., Lacomblez L., Vercelletto M., Thomas-Antérion C., Michel B.F., Golfier V., Didic M., Salachas F., Duyckaerts C., Cruts M., Verpillat P., Van Broeckhoven C., Brice A. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum. Mutat 2007, 28:846-855. French Research Network on FTD/FTD-MND.
21. Ghani M., Pinto D., Lee J.H., Grinberg Y., Sato C., Moreno D., Scherer S.W., Mayeux R., St.George-Hyslop P., Rogaeva E. Genome-wide survey of large rare copy number variations in Alzheimer's disease among Caribbean Hispanics. G3 (Bethesda) 2012, 2:71-78.
22. Padovani A., Agosti C., Premi E., Bellelli G., Borroni B. Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlations. Neurosci. Lett 2007, 422:39-42.
23. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol 1998, 43:815-825.
24. Ratnavalli E., Brayne C., Dawson K., Hodges J.R. The prevalence of frontotemporal dementia. Neurology 2002, 58:1615-1621.
25. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Hölttä-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chiò A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. ITALSGEN Consortium.
26. Rosso S.M., Donker Kaat L., Baks T., Joosse M., de Koning I., Pijnenburg Y., de Jong D., Dooijes D., Kamphorst W., Ravid R., Niermeijer M.F., Verheij F., Kremer H.P., Scheltens P., van Duijn C.M., Heutink P., van Swieten J.C. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 2003, 126:2016-2022.
27. Shankaran S.S., Capell A., Hruscha A.T., Fellerer K., Neumann M., Schmid B., Haass C. Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. J. Biol. Chem 2008, 283:1744-1753.
28. van der Zee J., Le Ber I., Maurer-Stroh S., Engelborghs S., Gijselinck I., Camuzat A., Brouwers N., Vandenberghe R., Sleegers K., Hannequin D., Dermaut B., Schymkowitz J., Campion D., Santens P., Martin J.J., Lacomblez L., De Pooter T., Peeters K., Mattheijssens M., Vercelletto M., Van den Broeck M., Cruts M., De Deyn P.P., Rousseau F., Brice A., Van Broeckhoven C. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum. Mutat 2007, 28:416.
29. Wang J., Van Damme P., Cruchaga C., Gitcho M.A., Vidal J.M., Seijo-Martínez M., Wang L., Wu J.Y., Robberecht W., Goate A. Pathogenic cysteine mutations affect progranulin function and production of mature granulins. J. Neurochem 2010, 112:1305-1315.